News
IDEAYA Biosciences Announces ASCO 2024 Oral Presentation For Darovasertib In Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study
24 Apr 24
Biotech, News, General
IDEAYA Biosciences Has Selected Move-Forward Phase 2 Expansion Dose For IDE397 Monotherapy In MTAP-Deletion Squamous Non-small Cell Lung Cancer, Based On The Adverse Event Profile And Preliminary Clinical Efficacy
22 Apr 24
Biotech, News, Health Care, General
Citigroup Maintains Buy on IDEAYA Biosciences, Raises Price Target to $60
21 Mar 24
News, Price Target, Analyst Ratings
Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews
8 Mar 24
Analyst Ratings
BTIG Initiates Coverage On IDEAYA Biosciences with Buy Rating, Announces Price Target of $55
8 Mar 24
News, Price Target, Initiation, Analyst Ratings
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts
21 Feb 24
Analyst Ratings
RBC Capital Maintains Outperform on IDEAYA Biosciences, Raises Price Target to $53
21 Feb 24
News, Price Target, Analyst Ratings
Recap: IDEAYA Biosciences Q4 Earnings
20 Feb 24
Earnings
IDEAYA Biosciences Q4 EPS $(0.52) Misses $(0.47) Estimate, Sales $3.92M Miss $8.84M Estimate
20 Feb 24
Earnings, News
The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts
26 Jan 24
Analyst Ratings
Goldman Sachs Maintains Buy on IDEAYA Biosciences, Raises Price Target to $53
26 Jan 24
News, Price Target, Analyst Ratings
Press releases
IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer
22 Apr 24
Press Releases
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
5 Apr 24
Press Releases
IDEAYA Biosciences to Participate in Upcoming April 2024 Investor Relations Event
1 Apr 24
Press Releases
IDEAYA Announces Clinical Collaboration to Evaluate IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer
12 Mar 24
Press Releases
IDEAYA Biosciences to Participate in Upcoming March 2024 Investor Relations Events
4 Mar 24
Press Releases
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
20 Feb 24
Earnings, Press Releases
IDEAYA Biosciences to Participate in Upcoming February 2024 Investor Relations Events
1 Feb 24
Press Releases
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
26 Jan 24
Press Releases